Reading AHR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track AHR free→Reading AHR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track AHR free→QuarterlyIQ Insights · AHR
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Other Events. As previously announced, on May 22, 2026, we closed the public offering of 14,000,000 shares, or the Offering, of our common stock, $0.01 par value per share, or Common Stock. In connection with the Offering, BofA Securities, Inc., as underwriter, or in such capacity, the Underwriter, was granted an option for 30 days to purchase up to 2,100,000 additional shares of Common Stock. On May 26, 2026, in connection with the exercise in full of the Underwriter’s option to purchase add…
Other Events. On May 22, 2026, we closed the public offering of 14,000,000 shares, or the Offering, of our common stock, $0.01 par value per share, or Common Stock. In connection with the Offering, we and American Healthcare REIT Holdings, LP, or our Operating Partnership, entered into an underwriting agreement on May 20, 2026, or the Underwriting Agreement, with BofA Securities, Inc., as underwriter, or in such capacity, the Underwriter, BofA Securities, Inc., as forward seller, or in such c…
Results of Operations and Financial Condition. On May 7, 2026, we issued an earnings release announcing our financial position as of March 31, 2026 and our results for the quarter then ended. A copy of the earnings release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Entry into a Material Definitive Agreement. The information reported in
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. As previously reported in our Current Report on Form 8-K filed on February 21, 2024, we, through American Healthcare REIT Holdings, LP, or our Operating Partnership, as borrower, certain of our subsidiaries, or the subsidiary guarantors, and our company, collectively as guarantors, entered into an agreement on February 14, 2024, or the 2024 Credit Agreement, that amended, restate…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangements of Certain Officers. On March 23, 2026, we and Mr. Hanson entered into an employment letter agreement, or the Employment Letter, with retroactive effect as of February 4, 2026, outlining the terms of Mr. Hanson’s service as our Interim Chief Executive Officer and President, or Interim CEO. Pursuant to the terms of the Employment Letter, Mr. Hanson will serve as Interim…
Entry into a Material Definitive Agreement. On February 27, 2026, we and American Healthcare REIT Holdings, LP, or our Operating Partnership, entered into an ATM Equity Offering Sales Agreement, or the Sales Agreement, with BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., Citizens JMP Securities, LLC, Credit Agricole Securities (USA) Inc., Fifth Third Securities, Inc., KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Regions Securit…
Results of Operations and Financial Condition. On February 26, 2026, we issued an earnings release announcing our financial position as of December 31, 2025 and our results for the quarter and year then ended. A copy of the earnings release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangements of Certain Officers. We announced today that Danny Prosky, our Chief Executive Officer, President and director, is taking a leave of absence, effective February 3, 2026, due to a recent medical event. Our board of directors has appointed Jeffrey T. Hanson, our Chairman of the Board and our former Chief Executive Officer from 2015 to 2021, to serve as our Interim Chief E…
Importance-ranked changes since the prior daily snapshot.
Valuation fell by 13.6 points (from 50.4 to 36.8).
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.